Business · 28/04/2005Updated: 10/17/2026 · 1 min read
FDA Announces Guidance for Evaluating Drug Exposure Risks in Human Pregnancies
Summary
The Food and Drug Administration (FDA) has released a guidance document to help its staff assess the risks of drug exposure during human pregnancies, aiming to improve product labeling for pregnant patients.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →